Synapse pathology in psychiatric and neurologic disease

Current Neurology and Neuroscience Reports

Volumn 10, Issue 3, 2010, Pages 207-214

  Van Spronsen, Myrrhe ^a   Hoogenraad, Casper C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Neurologic diseases; Psychiatric disorders; Spine morphology; Synapse pathology; Synaptic plasticity

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMATE TRANSPORTER; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUREXIN; NEUROLIGIN; POSTSYNAPTIC DENSITY PROTEIN 95;

ALZHEIMER DISEASE; AUTISM; BRAIN FUNCTION; DENDRITIC SPINE; DRUG DEPENDENCE; EXCITATORY POSTSYNAPTIC POTENTIAL; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; INHIBITORY POSTSYNAPTIC POTENTIAL; MENTAL DEFICIENCY; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PATHOLOGICAL ANATOMY; PRESYNAPTIC POTENTIAL; REVIEW; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; BIOLOGICAL MODEL; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SYNAPSE; ULTRASTRUCTURE;

DENDRITIC SPINES; HUMANS; MENTAL DISORDERS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY; NEURONS; SYNAPSES;

EID: 77954891060     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0104-8     Document Type: Review

References (50)

1. Yuste R, Bonhoeffer T: Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 2001, 24:1071-1089.
2. Pfeiffer BE, Huber KM: The state of synapses in fragile X syndrome. Neuroscientist 2009, 15(5):549-567.
3. Stephan KE, Baldeweg T, Friston KJ: Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 2006, 59 (10):929-939.
4. Calabresi P, Picconi B, Parnetti L, Di Filippo M: A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine- acetylcholine synaptic balance. Lancet Neurol 2006, 5(11):974-983.
5. Sudhof TC: Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455(7215):903-911.
6. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002, 298(5594):789-791.
7. Welch JM, Lu J, Rodriguiz RM, et al.: Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448(7156):894-900.
8. Kauer JA, Malenka RC: Synaptic plasticity and addiction. Nat Rev Neurosci 2007, 8(11):844-858.
9. Blanpied TA, Ehlers MD: Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biol Psychiatry 2004, 55(12):1121-1127.
10. Bourne JN, Harris KM: Balancing structure and function at hippocampal dendritic spines. Annu Rev Neurosci 2008, 31:47-67.
11. Sheng M, Hoogenraad CC: The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 2007, 76:823-847.
12. Craig AM, Graf ER, Linhoff MW: How to build a central synapse: clues from cell culture. Trends Neurosci 2006, 29(1):8-20.
13. Arikkath J, Reichardt LF: Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci 2008, 31(9):487-494.
14. Sudhof TC: The synaptic vesicle cycle. Annu Rev Neurosci 2004, 27:509-547.
15. Jin Y, Garner CC: Molecular mechanisms of presynaptic differentiation. Annu Rev Cell Dev Biol 2008, 24:237-262.
16. Waxman EA, Giasson BI: Molecular mechanisms of alphasynuclein neurodegeneration. Biochim Biophys Acta 2009, 1792 (7):616-624.
17. Malinow R, Malenka RC: AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002, 25:103-126.
18. Jacob TC, Moss SJ, Jurd R: GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci 2008, 9(5):331-343.
19. Sobolevsky AI, Rosconi MP, Gouaux E: X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 2009, 462(7274):745-756.
20. Chen X, Winters C, Azzam R, et al.: Organization of the core structure of the postsynaptic density. Proc Natl Acad Sci U S A 2008, 105(11):4453-4458.
21. Kennedy MB, Beale HC, Carlisle HJ, Washburn LR: Integration of biochemical signalling in spines. Nat Rev Neurosci 2005, 6 (6):423-434.
22. Renner M, Specht CG, Triller A: Molecular dynamics of postsynaptic receptors and scaffold proteins. Curr Opin Neurobiol 2008, 18(5):532-540.
23. Holtmaat A, Svoboda K: Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci 2009, 10 (9):647-658.
24. Kasai H, Matsuzaki M, Noguchi J, et al.: Structure-stabilityfunction relationships of dendritic spines. Trends Neurosci 2003, 26(7):360-368.
25. Yoshihara Y, De Roo M, Muller D: Dendritic spine formation and stabilization. Curr Opin Neurobiol 2009, 19(2):146-153.
26. Tada T, Sheng M: Molecular mechanisms of dendritic spine morphogenesis. Curr Opin Neurobiol 2006, 16(1):95-101.
27. •• Wang Z, Edwards JG, Riley N, et al.: Myosin Vb mobilizes recycling endosomes and AMPA receptors for postsynaptic plasticity. Cell 2008, 135(3):535-548. This high-quality imaging study illustrates that the actin-dependent motor protein MyoVb conducts RE and AMPA receptor trafficking during LTP. Upon activation of NMDA receptors and corresponding Ca2+ influx, MyoVb associates with REs and triggers rapid recruitment to dendritic spines for subsequent AMPA receptor insertion and spine growth.
28. Schlager MA, Hoogenraad CC: Basic mechanisms for recognition and transport of synaptic cargos. Mol Brain 2009, 2(1):25.
29. •• Jaworski J, Kapitein LC, Gouveia SM, et al.: Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 2009, 61(1):85-100. This article provides, for the first time, strong evidence that dynamic microtubules transiently enter dendritic spine and modulate spine actin dynamics. This study shows how the interplay between microtubules and actin cytoskeleton regulates spine morphology and suggests an unexplored function of microtubules in regulating postsynaptic function at glutamatergic synapses.
30. Hoogenraad CC, Bradke F: Control of neuronal polarity and plasticity-a renaissance for microtubules? Trends Cell Biol 2009, 19(12):669-676.
31. Newey SE, Velamoor V, Govek EE, Van Aelst L: Rho GTPases, dendritic structure, and mental retardation. J Neurobiol 2005, 64 (1):58-74.
32. Hoogenraad CC, Akhmanova A, Galjart N, De Zeeuw CI: LIMK1 and CLIP-115: linking cytoskeletal defects to Williams syndrome. Bioessays 2004, 26(2):141-150.
33. Gotz J, Ittner LM: Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008, 9(7):532-544.
34. Lau CG, Zukin RS: NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007, 8(6):413-426.
35. Dolen G, Bear MF: Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol 2008, 586(6):1503-1508.
36. Lord C, Cook EH, Leventhal BL, Amaral DG: Autism spectrum disorders. Neuron 2000, 28(2):355-363.
37. Abrahams BS, Geschwind DH: Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9 (5):341-355.
38. •• Tabuchi K, Blundell J, Etherton MR, et al.: A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318(5847):71-76. This interesting study from the Sudhof laboratory shows that a knockin mutant mouse that carries a point mutation in the gene encoding NLGN-3, known to cause monogenic heritable autism in humans, has impaired social behavior, enhanced spatial memory, and aberrant synaptic transmission at GABAergic synapses. This mouse model is an important tool in developing new diagnostic and therapeutic strategies in autism research.
39. Wang K, Zhang H, Ma D, et al.: Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459(7246):528-533.
40. Hagerman RJ, Ono MY, Hagerman PJ: Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry 2005, 18(5):490-496.
41. Brouwer JR, Willemsen R, Oostra BA: Microsatellite repeat instability and neurological disease. Bioessays 2009, 31(1):71-83.
42. Bassell GJ, Warren ST: Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60(2):201-214.
43. • Zalfa F, Eleuteri B, Dickson KS, et al.: A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 2007, 10(5):578-587. In this study, Zalfa et al. found that FMRP controls mRNA stability. FMRP binding to the 3' untranslated region of the PSD-95 mRNA increases message stability. Therefore, the authors suggest that dysregulation of PSD-95 mRNA stability may contribute to the cognitive impairment in individuals with FXS.
44. • Shankar GM, Li S, Mehta TH, et al.: Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008, 14(8):837-842. This study extracted soluble Aβ oligomers directly from the cerebral cortex of human subjects with AD and showed enhanced LTD and reduced dendritic spine density in normal rodent hippocampus. The data conclusively show that soluble Aβ oligomers extracted from AD brains potently impair synapse structure and function.
45. Kang JE, Lim MM, Bateman RJ, et al.: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326(5955):1005-1007.
46. Hsieh H, Boehm J, Sato C, et al.: AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006, 52(5):831-843.
47. • Cirrito JR,Kang JE, Lee J, et al.: Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 2008, 58 (1):42-51. Cirrito et al. report an interesting observation, that inhibition of clathrin-mediated endocytosis immediately lowers Aβ levels in vivo. These findings have implications for AD pathogenesis and may provide insights into therapeutic intervention.
48. Kalivas PW: The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 2009, 10(8):561-572.
49. • Huang YH, Lin Y, Mu P, et al.: In vivo cocaine experience generates silent synapses. Neuron 2009, 63(1):40-47. This article demonstrates that exposure to cocaine generates silent synapses in brain regions mediating addiction-related learning and memory. Interestingly, this cocaine-induced generation of silent synapses is mediated by membrane insertions of new NMDA receptors. Thus, silent synapses may be generated de novo by in vivo addictive experiences.
50. Ramocki MB, Zoghbi HY: Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008, 455 (7215):912-918.